IGF-1 protects tubular epithelial cells during injury via activation of ERK/MAPK signaling pathway

Sci Rep. 2016 Jun 15:6:28066. doi: 10.1038/srep28066.

Abstract

Injury of renal tubular epithelial cells can induce acute renal failure and obstructive nephropathy. Previous studies have shown that administration of insulin-like growth factor-1 (IGF-1) ameliorates the renal injury in a mouse unilateral ureteral obstruction (UUO) model, whereas the underlying mechanisms are not completely understood. Here, we addressed this question. We found that the administration of IGF-1 significantly reduced the severity of the renal fibrosis in UUO. By analyzing purified renal epithelial cells, we found that IGF-1 significantly reduced the apoptotic cell death of renal epithelial cells, seemingly through upregulation of anti-apoptotic protein Bcl-2, at protein but not mRNA level. Bioinformatics analyses and luciferase-reporter assay showed that miR-429 targeted the 3'-UTR of Bcl-2 mRNA to inhibit its protein translation in renal epithelial cells. Moreover, IGF-1 suppressed miR-429 to increase Bcl-2 in renal epithelial cells to improve survival after UUO. Furthermore, inhibition of ERK/MAPK signaling pathway in renal epithelial cells abolished the suppressive effects of IGF-1 on miR-429 activation, and then the enhanced effects on Bcl-2 in UUO. Thus, our data suggest that IGF-1 may protect renal tubular epithelial cells via activation of ERK/MAPK signaling pathway during renal injury.

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Cell Proliferation
  • Cells, Cultured
  • Disease Models, Animal
  • Epithelial Cells / cytology
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism
  • Insulin-Like Growth Factor I / administration & dosage*
  • Insulin-Like Growth Factor I / pharmacology
  • Kidney Diseases / etiology
  • Kidney Diseases / genetics
  • Kidney Diseases / metabolism
  • Kidney Diseases / prevention & control*
  • Kidney Tubules / cytology
  • Kidney Tubules / drug effects*
  • Kidney Tubules / metabolism
  • MAP Kinase Signaling System / drug effects*
  • Male
  • Mice
  • MicroRNAs / genetics
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Up-Regulation

Substances

  • MIRN429 microRNA, mouse
  • MicroRNAs
  • Proto-Oncogene Proteins c-bcl-2
  • Bcl2 protein, mouse
  • Insulin-Like Growth Factor I